Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hearing Loss, Noise-Induced | 21 | 2022 | 145 | 4.080 |
Why?
|
Cochlea | 31 | 2022 | 828 | 3.590 |
Why?
|
Otoacoustic Emissions, Spontaneous | 22 | 2018 | 136 | 2.910 |
Why?
|
Cochlear Nerve | 8 | 2021 | 197 | 2.150 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 12 | 2021 | 250 | 2.140 |
Why?
|
Auditory Threshold | 23 | 2021 | 364 | 2.110 |
Why?
|
Noise | 17 | 2022 | 278 | 1.970 |
Why?
|
Hearing | 6 | 2019 | 482 | 1.840 |
Why?
|
Synapses | 9 | 2021 | 1728 | 1.660 |
Why?
|
Mice, Inbred CBA | 15 | 2021 | 448 | 1.190 |
Why?
|
Hearing Loss, Sensorineural | 4 | 2018 | 770 | 1.170 |
Why?
|
Hair Cells, Auditory, Inner | 7 | 2021 | 191 | 1.040 |
Why?
|
Presbycusis | 4 | 2019 | 42 | 1.000 |
Why?
|
Hair Cells, Auditory, Outer | 6 | 2019 | 98 | 1.000 |
Why?
|
Acoustic Stimulation | 26 | 2022 | 1209 | 1.000 |
Why?
|
Evoked Potentials, Auditory | 10 | 2018 | 504 | 0.930 |
Why?
|
Auditory Perception | 5 | 2019 | 566 | 0.840 |
Why?
|
Nerve Degeneration | 5 | 2017 | 748 | 0.760 |
Why?
|
Aging | 9 | 2019 | 8655 | 0.690 |
Why?
|
Ear, Middle | 2 | 2016 | 334 | 0.670 |
Why?
|
Guinea Pigs | 24 | 2016 | 1386 | 0.660 |
Why?
|
Cochlear Diseases | 2 | 2018 | 23 | 0.630 |
Why?
|
Synaptic Transmission | 8 | 2018 | 1176 | 0.610 |
Why?
|
Hair Cells, Auditory | 8 | 2015 | 361 | 0.560 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 158 | 0.520 |
Why?
|
Tinnitus | 3 | 2023 | 195 | 0.470 |
Why?
|
Drug Delivery Systems | 8 | 2016 | 2217 | 0.430 |
Why?
|
Perilymph | 7 | 2009 | 49 | 0.430 |
Why?
|
Olivary Nucleus | 6 | 1999 | 128 | 0.410 |
Why?
|
Spiral Ganglion | 7 | 2018 | 169 | 0.410 |
Why?
|
Hearing Loss | 5 | 2023 | 765 | 0.320 |
Why?
|
Receptors, AMPA | 4 | 2018 | 332 | 0.290 |
Why?
|
Blast Injuries | 2 | 2023 | 302 | 0.280 |
Why?
|
Animals | 48 | 2022 | 168660 | 0.260 |
Why?
|
Noise, Occupational | 1 | 2005 | 26 | 0.260 |
Why?
|
Hearing Disorders | 1 | 2005 | 124 | 0.250 |
Why?
|
Ear, Inner | 4 | 2018 | 420 | 0.250 |
Why?
|
Infusion Pumps | 2 | 2016 | 163 | 0.250 |
Why?
|
Quinoxalines | 4 | 2015 | 289 | 0.240 |
Why?
|
Occupational Exposure | 3 | 2012 | 1787 | 0.240 |
Why?
|
Vestibulocochlear Nerve | 2 | 1994 | 116 | 0.240 |
Why?
|
Excitatory Amino Acid Antagonists | 5 | 2011 | 449 | 0.240 |
Why?
|
Salicylates | 3 | 2005 | 126 | 0.230 |
Why?
|
Occupational Diseases | 1 | 2012 | 1466 | 0.230 |
Why?
|
Meniere Disease | 4 | 2006 | 161 | 0.230 |
Why?
|
Neurons, Efferent | 2 | 1995 | 82 | 0.230 |
Why?
|
Industry | 1 | 2005 | 366 | 0.220 |
Why?
|
Microfluidics | 3 | 2015 | 662 | 0.200 |
Why?
|
Vestibulocochlear Nerve Diseases | 2 | 2013 | 31 | 0.200 |
Why?
|
Mice | 20 | 2022 | 81154 | 0.200 |
Why?
|
Auditory Pathways | 2 | 2015 | 233 | 0.180 |
Why?
|
Neurons, Afferent | 4 | 2010 | 504 | 0.180 |
Why?
|
Cochlear Microphonic Potentials | 3 | 1996 | 22 | 0.180 |
Why?
|
Sensory Receptor Cells | 2 | 2018 | 493 | 0.180 |
Why?
|
Explosions | 2 | 2023 | 108 | 0.170 |
Why?
|
Auditory Cortex | 2 | 2022 | 345 | 0.170 |
Why?
|
Bicycling | 1 | 2021 | 176 | 0.170 |
Why?
|
Species Specificity | 2 | 2019 | 2480 | 0.160 |
Why?
|
Models, Animal | 1 | 2005 | 2172 | 0.160 |
Why?
|
Alcohol Oxidoreductases | 2 | 2018 | 170 | 0.160 |
Why?
|
Co-Repressor Proteins | 2 | 2018 | 194 | 0.160 |
Why?
|
Cell Death | 3 | 2015 | 1705 | 0.160 |
Why?
|
Ouabain | 1 | 2018 | 264 | 0.160 |
Why?
|
Feedback | 1 | 2001 | 795 | 0.150 |
Why?
|
Music | 1 | 2021 | 262 | 0.150 |
Why?
|
Afferent Pathways | 1 | 2018 | 302 | 0.150 |
Why?
|
Conditioning, Classical | 1 | 1999 | 366 | 0.140 |
Why?
|
Saccule and Utricle | 3 | 2006 | 81 | 0.140 |
Why?
|
Tympanic Membrane Perforation | 1 | 2014 | 41 | 0.130 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18027 | 0.120 |
Why?
|
Time Factors | 9 | 2018 | 40038 | 0.120 |
Why?
|
Hyperacusis | 1 | 2014 | 31 | 0.120 |
Why?
|
Recurrent Laryngeal Nerve | 1 | 2016 | 139 | 0.120 |
Why?
|
Military Personnel | 1 | 2023 | 1133 | 0.120 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 1994 | 71 | 0.120 |
Why?
|
Temporal Bone | 2 | 2011 | 661 | 0.120 |
Why?
|
Scala Tympani | 2 | 2011 | 35 | 0.120 |
Why?
|
Calcium | 4 | 2022 | 5755 | 0.120 |
Why?
|
Glutamic Acid | 3 | 2017 | 1168 | 0.120 |
Why?
|
Psychoacoustics | 1 | 2013 | 57 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 712 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 1996 | 692 | 0.110 |
Why?
|
Action Potentials | 6 | 2009 | 1804 | 0.110 |
Why?
|
Receptors, Cholinergic | 1 | 1993 | 238 | 0.110 |
Why?
|
Male | 34 | 2021 | 349776 | 0.100 |
Why?
|
Neonatal Screening | 1 | 2016 | 590 | 0.100 |
Why?
|
Labyrinth Diseases | 2 | 2010 | 150 | 0.100 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2016 | 428 | 0.100 |
Why?
|
Age Factors | 3 | 2019 | 18355 | 0.100 |
Why?
|
Adenosine Triphosphate | 2 | 1994 | 2029 | 0.100 |
Why?
|
Receptors, Nicotinic | 1 | 1994 | 497 | 0.090 |
Why?
|
Audiometry, Pure-Tone | 3 | 2006 | 204 | 0.090 |
Why?
|
Excitatory Amino Acid Transporter 1 | 1 | 2010 | 19 | 0.090 |
Why?
|
Excitatory Amino Acid Transporter 3 | 1 | 2010 | 32 | 0.090 |
Why?
|
Acetylcholine | 1 | 1992 | 619 | 0.090 |
Why?
|
Ganglia, Sensory | 1 | 2009 | 20 | 0.090 |
Why?
|
Curare | 3 | 1995 | 10 | 0.090 |
Why?
|
Phosphoproteins | 2 | 2018 | 2440 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1619 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 3769 | 0.090 |
Why?
|
Strychnine | 3 | 1994 | 33 | 0.090 |
Why?
|
Glucose Transporter Type 1 | 1 | 2010 | 194 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 828 | 0.080 |
Why?
|
Gentamicins | 1 | 2010 | 255 | 0.080 |
Why?
|
Mastoid | 1 | 2009 | 92 | 0.080 |
Why?
|
Infusion Pumps, Implantable | 1 | 2009 | 156 | 0.080 |
Why?
|
Female | 29 | 2021 | 380020 | 0.080 |
Why?
|
Wakefulness | 1 | 2015 | 1243 | 0.080 |
Why?
|
Vestibular Function Tests | 2 | 2006 | 127 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 505 | 0.080 |
Why?
|
Electrophysiology | 4 | 1998 | 1297 | 0.080 |
Why?
|
Neurons | 4 | 2013 | 9336 | 0.070 |
Why?
|
Endolymphatic Hydrops | 1 | 2006 | 30 | 0.070 |
Why?
|
Electromyography | 3 | 2006 | 1378 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2014 | 2018 | 0.070 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 533 | 0.070 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2005 | 58 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 2 | 2014 | 1854 | 0.070 |
Why?
|
Anesthesiology | 1 | 2016 | 1060 | 0.070 |
Why?
|
Deafness | 2 | 2018 | 458 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10394 | 0.070 |
Why?
|
Efferent Pathways | 2 | 1997 | 167 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2281 | 0.060 |
Why?
|
Humans | 24 | 2023 | 743811 | 0.060 |
Why?
|
Bicuculline | 2 | 1995 | 94 | 0.060 |
Why?
|
Nicotinic Antagonists | 2 | 1995 | 96 | 0.060 |
Why?
|
Vestibular Nerve | 1 | 2004 | 101 | 0.060 |
Why?
|
Cochlear Implants | 1 | 2009 | 339 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5611 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.060 |
Why?
|
Syncope | 1 | 2006 | 429 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
Miniaturization | 2 | 2015 | 164 | 0.050 |
Why?
|
Bone Remodeling | 1 | 2006 | 569 | 0.050 |
Why?
|
Reference Values | 2 | 2006 | 4974 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 9648 | 0.050 |
Why?
|
Sensory Thresholds | 2 | 2006 | 391 | 0.050 |
Why?
|
Evoked Potentials, Motor | 1 | 2004 | 454 | 0.050 |
Why?
|
Spectrin | 1 | 2001 | 177 | 0.050 |
Why?
|
Otitis Media | 1 | 2003 | 277 | 0.050 |
Why?
|
Flavones | 1 | 2021 | 66 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 871 | 0.050 |
Why?
|
Amitriptyline | 1 | 2021 | 110 | 0.050 |
Why?
|
Environmental Exposure | 2 | 2006 | 4232 | 0.050 |
Why?
|
Tremor | 1 | 2001 | 177 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4463 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2012 | 13980 | 0.040 |
Why?
|
Equipment Design | 3 | 2015 | 3574 | 0.040 |
Why?
|
Cell Membrane | 1 | 2009 | 3749 | 0.040 |
Why?
|
Prospective Studies | 5 | 2014 | 53250 | 0.040 |
Why?
|
Sound | 1 | 2021 | 260 | 0.040 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2018 | 28 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2016 | 25609 | 0.040 |
Why?
|
Receptors, Glutamate | 2 | 2009 | 232 | 0.040 |
Why?
|
Functional Laterality | 3 | 2006 | 2280 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2018 | 379 | 0.040 |
Why?
|
Glycoproteins | 1 | 2006 | 2266 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2021 | 1342 | 0.040 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1996 | 36 | 0.040 |
Why?
|
Nimodipine | 1 | 1996 | 55 | 0.040 |
Why?
|
Perfusion | 2 | 2005 | 1359 | 0.040 |
Why?
|
Egtazic Acid | 1 | 1996 | 173 | 0.040 |
Why?
|
Denervation | 1 | 1997 | 278 | 0.040 |
Why?
|
Adult | 11 | 2021 | 213889 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 494 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3639 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4033 | 0.030 |
Why?
|
Dimethyl Sulfoxide | 1 | 1996 | 250 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2005 | 10940 | 0.030 |
Why?
|
GABA Antagonists | 1 | 1995 | 126 | 0.030 |
Why?
|
Drug Administration Routes | 1 | 2015 | 154 | 0.030 |
Why?
|
Suramin | 1 | 1994 | 34 | 0.030 |
Why?
|
Chelating Agents | 1 | 1996 | 379 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1008 | 0.030 |
Why?
|
Microtechnology | 1 | 2015 | 69 | 0.030 |
Why?
|
Neck Dissection | 1 | 2016 | 197 | 0.030 |
Why?
|
Tympanoplasty | 1 | 2014 | 71 | 0.030 |
Why?
|
Stria Vascularis | 1 | 1994 | 31 | 0.030 |
Why?
|
Thionucleotides | 1 | 1994 | 107 | 0.030 |
Why?
|
Inferior Colliculi | 1 | 1995 | 68 | 0.030 |
Why?
|
Bungarotoxins | 1 | 1994 | 46 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1994 | 192 | 0.030 |
Why?
|
Hearing Tests | 1 | 2014 | 122 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2005 | 2002 | 0.030 |
Why?
|
Parathyroid Glands | 1 | 2016 | 509 | 0.030 |
Why?
|
Perception | 1 | 2021 | 1198 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 1994 | 156 | 0.030 |
Why?
|
Stereoisomerism | 1 | 1994 | 624 | 0.030 |
Why?
|
Muscarinic Antagonists | 1 | 1994 | 137 | 0.030 |
Why?
|
Magnesium | 1 | 1996 | 813 | 0.030 |
Why?
|
Atropine | 1 | 1993 | 244 | 0.030 |
Why?
|
Physostigmine | 1 | 1992 | 53 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2006 | 6356 | 0.030 |
Why?
|
Triazines | 1 | 1994 | 315 | 0.030 |
Why?
|
Cell Size | 1 | 1994 | 641 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1486 | 0.030 |
Why?
|
Coloring Agents | 1 | 1994 | 565 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7172 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2453 | 0.020 |
Why?
|
Risk Factors | 2 | 2017 | 72252 | 0.020 |
Why?
|
Young Adult | 3 | 2012 | 56392 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 879 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 21824 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2009 | 0.020 |
Why?
|
Hydrodynamics | 1 | 2011 | 158 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 1998 | 1420 | 0.020 |
Why?
|
Dosage Forms | 1 | 2009 | 56 | 0.020 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2009 | 70 | 0.020 |
Why?
|
Cohort Studies | 6 | 2014 | 40545 | 0.020 |
Why?
|
Restraint, Physical | 1 | 2011 | 193 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 12066 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 831 | 0.020 |
Why?
|
Amino Acids | 1 | 1995 | 1733 | 0.020 |
Why?
|
N-Methylaspartate | 1 | 2009 | 231 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2011 | 583 | 0.020 |
Why?
|
Neurotoxins | 1 | 2009 | 237 | 0.020 |
Why?
|
Membrane Potentials | 1 | 1991 | 1137 | 0.020 |
Why?
|
Extracellular Space | 1 | 2010 | 595 | 0.020 |
Why?
|
Calcium Channels | 1 | 1991 | 622 | 0.020 |
Why?
|
Electronics | 1 | 2009 | 321 | 0.020 |
Why?
|
Exocytosis | 1 | 2009 | 354 | 0.020 |
Why?
|
Electric Stimulation | 1 | 1992 | 1760 | 0.020 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2007 | 146 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1999 | 2401 | 0.020 |
Why?
|
Acoustic Impedance Tests | 1 | 2006 | 109 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20121 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4737 | 0.020 |
Why?
|
Osteoprotegerin | 1 | 2006 | 176 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 975 | 0.020 |
Why?
|
Incidence | 1 | 2003 | 20948 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11360 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2429 | 0.020 |
Why?
|
Brain Stem | 1 | 2009 | 844 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2241 | 0.010 |
Why?
|
Neck Muscles | 1 | 2004 | 103 | 0.010 |
Why?
|
Case-Control Studies | 3 | 2006 | 21733 | 0.010 |
Why?
|
Dexamethasone | 1 | 2011 | 1950 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14563 | 0.010 |
Why?
|
Kinetics | 1 | 2011 | 6476 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15067 | 0.010 |
Why?
|
Mutation | 2 | 2011 | 29777 | 0.010 |
Why?
|
Vestibule, Labyrinth | 1 | 2004 | 235 | 0.010 |
Why?
|
Models, Biological | 2 | 2011 | 9582 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2725 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2203 | 0.010 |
Why?
|
Algorithms | 2 | 2016 | 13869 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 14714 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2251 | 0.010 |
Why?
|
Aged | 6 | 2011 | 163178 | 0.010 |
Why?
|
Audiometry | 1 | 2000 | 241 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2001 | 641 | 0.010 |
Why?
|
Nanoparticles | 1 | 2010 | 1898 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2011 | 57744 | 0.010 |
Why?
|
Middle Aged | 6 | 2011 | 213241 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2001 | 1862 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6188 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5952 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 13028 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2011 | 4245 | 0.010 |
Why?
|
Aminoisobutyric Acids | 1 | 1995 | 37 | 0.010 |
Why?
|
Microdialysis | 1 | 1995 | 158 | 0.010 |
Why?
|
Child | 2 | 2014 | 77637 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4749 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 12788 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19232 | 0.010 |
Why?
|
Aspartic Acid | 1 | 1995 | 576 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1995 | 1422 | 0.010 |
Why?
|
Calibration | 1 | 1995 | 816 | 0.010 |
Why?
|
Adolescent | 2 | 2011 | 85729 | 0.010 |
Why?
|
Glycine | 1 | 1995 | 670 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1995 | 1574 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12243 | 0.010 |
Why?
|
Potassium | 1 | 1995 | 1336 | 0.010 |
Why?
|
Infant | 1 | 2011 | 35122 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13273 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1995 | 1118 | 0.010 |
Why?
|
Child, Preschool | 1 | 2011 | 40964 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 1995 | 1018 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18107 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15526 | 0.000 |
Why?
|
Massachusetts | 1 | 2000 | 8660 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2006 | 77410 | 0.000 |
Why?
|